Personalized onco-genomics
Personalized Onco-Genomics
Personalized Onco-Genomics (POG) (pronunciation: /pɜːr.sən.əl.aɪzd ɒŋ.kəʊ dʒɪˈnɒm.ɪks/) is a scientific approach in the field of oncology that involves the use of genomic data to tailor cancer treatments to individual patients.
Etymology
The term "Personalized Onco-Genomics" is a combination of three words: "personalized", "onco-" (from the Greek "ónkos" meaning mass or tumor), and "-genomics" (from the Greek "genomikos" meaning gene). It reflects the application of genomic information to provide personalized treatment strategies for cancer patients.
Definition
Personalized Onco-Genomics is a program that uses whole genome sequencing and transcriptome sequencing to identify potential therapeutic targets based on the unique genomic makeup of a patient's tumor. The goal of POG is to improve patient outcomes by selecting treatments that are most likely to be effective for the individual patient, based on the genetic characteristics of their tumor.
Related Terms
- Genomics: The study of the genomes of organisms.
- Oncology: The study and treatment of tumors.
- Whole genome sequencing: A laboratory process that determines the complete DNA sequence of an organism's genome at a single time.
- Transcriptome sequencing: The process of sequencing the RNA in a cell to study the cell's transcriptome, the sum total of all the messenger RNA molecules expressed from the genes of an organism.
See Also
External links
- Medical encyclopedia article on Personalized onco-genomics
- Wikipedia's article - Personalized onco-genomics
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski